The largest Insider Buys this week were for Abbott Laboratories (ABT), Chevron Corp. (CVX), Zoetis Inc. (ZTS), and Ford Motor Co. (F).

Abbott Laboratories (ABT): Director Michelle Kumbier bought 2,040 shares

Director Michelle Kumbier bought 2,040 shares on Feb. 23 at the average price of $122.50. The price of the stock has decreased by 2.22% since.

Abbott Laboratories is an American healthcare company that focuses on developing and marketing research-based drugs, medical devices and nutritional products. The company's in-vitro diagnostics business also performs immunoassays and blood screening. The company has a market capitalization of $212.19 billion, and as of Feb.

The MS Global Franchise Fund (Trades, Portfolio), which is part of investment bank Morgan Stanley (MS), disclosed its third-quarter portfolio earlier this week.

Managed by a nine-person team, the New York-based fund invests in high-quality companies from around the world in order to achieve long-term capital appreciation. It looks for companies that have resilient business franchises and growth potential.

Sticking to these criteria, the fund entered one new position during the quarter and added to or trimmed a slew of existing holdings. Its most notable trades for the quarter included a new investment in Intercontinental Exchange Inc.

U.S. stocks were in the red on Thursday with utilities and materials leading declines in the indexes. The Dow Jones Industrial Average fell 1.24% to 24,329, the S&P 500 Index declined 1.1% to 2,907 and the Nasdaq Composite Index dipped 0.6% to 8,861.

Non-index stocks have also posted gains and losses recently. Shares of McDonald's Corp. (MCD) fell more than 1% on Thursay after the company announced first-quarter results. It posted earnings of

Among other pleasures quashed by the pandemic, the baseball season will be delayed (let’s hope not cancelled).

However, as a minor consolation, my 30-30 Club continues.

In baseball, the 30-30 Club contains players who have hit 30 home runs and stolen 30 bases in the same season. In the past 100 years, only 41 players have done it. Last year two players did: Ronald Acuna of the Atlanta Braves and Christian Yelich of the Milwaukee Brewers.

My 30-30 club is for corporations. To make it, a company must show a 30% return on stockholders’ equity (high profitability) and a 30%

According to GuruFocus Insider Data, the recent CFO sells were for Regeneron Pharmaceuticals Inc. (REGN), Zoetis Inc. (ZTS) and Zoom Video Communications Inc. (ZM).

Regeneron Pharmaceuticals Inc. Executive Vice President Finance CFO Robert E. Landry sold 414 shares

Executive Vice President Finance CFO Robert E. Landry sold 414 shares for $452.49 per share on Feb. 26. Since then, the stock price has increased by 2.89%.

Regeneron Pharmaceuticals Inc. has a market cap of $51.22 billion and its shares were traded around $465.55. The company has a price-earnings ratio of 25.22 and price-sales ratio of 6.77. Over the past five years,

“Dog is a man’s best friend.” This old saying has seen its business implications increasing these days. According to multiple studies, 98% of pet owners consider their companion animals to be full members of the family, and more than half of them admit enjoying the company of their pet even more than that of their human best friends.

That feeling of love for companion animals is often reflected on bank statements. The American Pet Products Association (referred to as “APPA”) estimates a nearly $75 billion pet economy in the U.S. Moreover, the domain has been expanding steadily thanks to the

Shareholders of Zoetis Inc (ZTS), Shiseido Company Limited (SSDOY) and TransUnion (TRU) have reason to be satisfied as their holdings have delivered large gains over the past several years, topping the S&P 500 index significantly.

Their ability to generate higher than expected earnings has led their share prices higher is reflected by their GuruFocus profitability score, which measures varios aspects of a company's ability to turn profits.

Wall Street expects these stocks to continue performing well, as its sell-side analysts have issued an overweight recommendation rating for all three of them.

Zoetis

Shares of Zoetis Inc have risen 65% over

The MS Global Franchise Fund (Trades, Portfolio), which is part of Morgan Stanley (MS), released its third-quarter portfolio last week, disclosing it established one new position and exited another.

Managed by a nine-person team, the New York-based fund invests in high-quality companies around the world in order to achieve long-term capital appreciation. It looks for companies that have resilient business franchises and growth potential.

Based on these criteria, the fund opened a position in Thermo Fisher Scientific Inc. (TMO) and closed out of its Clorox Co. (CLX) holding during the quarter.

Thermo Fisher Scientific

The portfolio managers

Economic and Market Conditions

Amid trade war fears and slowing economic growth, U.S. and global stocks delivered mixed returns for the 12-month period ended August 31, 2019.

U.S. stocks opened the period in positive territory, but soon reversed course amid fears of a global trade war due to President Trump’s imposition of broad new import tariffs. However, U.S. economic data remained largely positive during the period, prompting the U.S. Federal Reserve Board (the Fed) in December 2018 to again raise its benchmark interest rate.

Stocks turned higher in early 2019 as trade fears eased and interest rates remained stable. U.S.

U.S. stocks gained on Tuesday after China devalued its currency to its lowest level since 2008. The Dow Jones Industrial Average rose 1.21% to 26,029, the S&P 500 Index gained 1.30% to 2,881 and the Nasdaq Composite Index gained 1.39% to 7,833.

Shares of Marriott International Inc. (MAR) fell more than 1% after announcing second-quarter results. The company posted earnings of $1.56 per share on $5.31 billion in revenue, reflecting a 1.8% decline from the prior-year quarter.